Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026

BOCA RATON, Fla.–(BUSINESS WIRE)–Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for the first quarter of 2026 on Thursday, May 7, 2026. Management will hold a conference call beginning at 4:30 pm Eastern … [Read more…]

New EndoTool IV Data Presented at AACE Show Virtual Elimination of Severe Hypoglycemia Across 19 Hospitals

Three-year analysis shows a 98% reduction in severe hypoglycemia, low severe hyperglycemia, and comparable safety in severe renal impairment. PALO ALTO, Calif. & LAS VEGAS–(BUSINESS WIRE)–Glooko, Inc., a globally integrated digital healthcare company focused on helping healthcare systems solve the growing challenges of glycemic safety and diabetes management across care settings, today announced data presented … [Read more…]

Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights

eyonis® LCS 510(k) clearance sets stage for commercialization in the United States New leadership of U.S. subsidiary and collaboration with Tempus accelerate rollout 28% reduction in operating loss in 2025 year‑over‑year, demonstrating strengthened cost discipline and operational efficiency iCRO order backlog reaches a new record at €79.8 million as of March 31, 2026 Cash and … [Read more…]

NorthStar Mapping System Now Commercially Available in the United States

MINNEAPOLIS–(BUSINESS WIRE)–#WeareiMR—Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce the U.S. commercial launch of its NorthStar® Mapping System. As the first and only cardiac mapping and guidance system designed specifically to harness the power of magnetic resonance (MR) imaging to see the heart throughout a minimally-invasive interventional procedure, NorthStar brings … [Read more…]

CatalYm Advances Visugromab into Phase 2/3 Development for Cancer Cachexia with First Patient Dosed

Trial will evaluate visugromab’s potential to reverse cancer-associated weight loss and muscle wasting by targeting GDF-15 in patients with advanced solid tumors Fourth Phase 2b study of visugromab broadens CatalYm’s late-stage development program into severe cancer-associated condition impacting treatment outcomes MUNICH & SAN FRANCISCO–(BUSINESS WIRE)–CatalYm today announced that the first patient has been dosed in … [Read more…]

Samsung Epis Holdings Reports First Quarter 2026 Financial Results

Samsung Bioepis recorded Q1’26 revenue of KRW 454.9 billion and operating profit of KRW 144.0 billion INCHEON, Korea–(BUSINESS WIRE)–#ADC–Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced its financial results for the first quarter of fiscal year 2026. “Samsung Bioepis delivered solid growth this quarter driven by … [Read more…]

ASP Announces Strategic Partnership With ChemDAQ to Advance Safety, Confidence, and Compliance in Sterile Processing

IRVINE, Calif.–(BUSINESS WIRE)–Advanced Sterilization Products (ASP), a global leader in infection prevention and low‑temperature sterilization, today announced a strategic partnership with ChemDAQ, a leading provider of hazardous gas detection and monitoring solutions. Together, ASP and ChemDAQ will support healthcare organizations by strengthening safety practices, reinforcing regulatory confidence, and advancing best‑in‑class sterile processing environments. As part … [Read more…]

AHF Webinar Spotlights Equity as Pandemic Agreement Nears Finish Line

Thursday, April 23, 10:00 AM EDT Miami, USA, via Zoom MIAMI–(BUSINESS WIRE)–#COVID–AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Will Equity Prevail? The PABS Annex Negotiations at Their Final Hour,” on Thursday, April 23, 2026 at 10:00 AM EDT, virtually via Zoom. Register here. … [Read more…]

Cambia Health Foundation Releases 2025 Community Impact Report

In 2025, the Foundation directed nearly $6.4 million in philanthropic investments through grants, employee giving and matching contributions. PORTLAND, Ore.–(BUSINESS WIRE)–Cambia Health Foundation released its 2025 Community Impact Report, highlighting purposeful philanthropic funding to advance whole-person health and the dedication Cambia employees demonstrated through volunteerism and monetary giving. The Foundation’s strategic investments aim to expand … [Read more…]

Ten IVI RMA North America Clinics Recognized in Newsweek’s ‘America’s Best Fertility Clinics’ 2026 Ranking

RMA Basking Ridge (#8 Overall, #1 in NJ), Boston IVF Waltham (#11 Overall, #2 in MA), Conceptions RMA Colorado (#2 in CO), Ohio Reproductive Medicine (#2 in OH), UNC Fertility (#2 in NC) and others included on list of top 140 U.S. clinics BASKING RIDGE, N.J.–(BUSINESS WIRE)–IVI RMA North America, a leader in fertility care … [Read more…]